Scientifical and technical partnership for the development of innovative injectable medical devices made of biopolymers

ANTEIS
Chemin des Aulx 18
1228
Plan-les-Ouates
1228 Plan-les-Ouates
Auf Karte anzeigen
Öffnungszeiten
MO: 08:00 - 17:00
Firmenbeschrieb
ANTEIS aims at becoming a reference company for the sub-contracted development of innovative medical devices made of biopolymers, especially in the field of sustained drug release devices.Für unsere Kunden sind wir einzigartig, weil We know how to functionnalise and transform biopolymers to realise efficient medical devices while keeping a high biocompatibility level and easy to use properties.
Gründungsjahr
2003
Rechtsform
-
Anzahl Mitarbeiter
6
Umsatz
2'500'000 CHF
MwSt-Nr
-
Handelsregister
-
Sprachen
Français, English
Zielmärkte
-
Marktleistungen
-
Developing under contract
For any products used for a medical or a pharmaceutical purpose, and essentially made of biopolymers, ANTEIS provides a full service of development, starting from the customer need until the scale-up of the manufacturing process, including feasibility study, prototyping, assitance for regulatory affairs, clinical survey, ...
Kernkompetenzen
Noch keine KernkompetenzenKooperationspartner
Noch keine KooperationspartnerKundengruppen
-
Company active in the Medical devices field
All companies looking for competences to develop new injectable medical devices made of biopolymers
-
Pharmaceutical companies
All pharmaceutical companies interested in a new sustained drug released system, with adjustable releasing profile for long term treatments
Referenzkunden
Noch keine ReferenzkundenZertifikate
-
CE 0120
Conformity assessment to DIR 93/42/CE Authorisation to market injectable medical devices made of biopolymers (for all product class IIb and lower)
-
ISO 9001, ISO 13485
-
CE 0120 (III)
Assessment of conformity to DIR 93/42/EC and 2003/32/EC Authorisation to market injectable products for skin tissues augmentation (class III product)
Mitgliedschaften
Noch keine MitgliedschaftenLinks
Noch keine LinksMehr über uns
-
Our products for Aesthetic Medicine : Esthélis
Esthélis is the first range of products coming from ANTEIS R&D. Esthélis uses the "Cohesive Polydensified Matrix" technology that enhances in-vivo lifetime and degradation profile (up to 6 months) and keeps the injection safe and user-friendly.
PDF 157 kB
www.esthelis.com
Eintrag erstellt: 11.10.2004, Letzte Änderung: 11.07.2005
